Metabolic manipulation in ischaemic heart disease, a novel approach to treatment

Antianginal drugs that exert their anti-ischaemic effects primarily by altering myocardial metabolism have recently attracted attention. They have the potential to relieve symptoms in patients with refractory angina who are already on “optimal” medical therapy and have disease that is not amenable t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2004-04, Vol.25 (8), p.634-641
Hauptverfasser:	Lee, Leong, Horowitz, John, Frenneaux, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetanilides Adrenergic beta-Antagonists - therapeutic use Angina Angina Pectoris - drug therapy Biological and medical sciences Cardiology. Vascular system Cardiovascular Agents - therapeutic use Coronary heart disease Drug Therapy, Combination Enzyme Inhibitors - therapeutic use Epoxy Compounds - therapeutic use Etomoxir Glucose - therapeutic use Heart Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Medical sciences Metabolism Myocardial Ischemia - drug therapy Myocardial Ischemia - metabolism Myocardium - metabolism Perhexiline Perhexiline - therapeutic use Piperazines - therapeutic use Potassium - therapeutic use Ranolazine Trimetazidine Trimetazidine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!